Adaptive support ventilation (ASV) is a microprocessor-controlled mode of mechanical ventilation that maintains a predefined minute ventilation with an optimal breathing pattern (tidal volume and rate) by automatically adapting inspiratory pressure and ventilator rate to changes in the patient's condition. The aim of the current study was to test the hypothesis that a protocol of respiratory weaning based on ASV could reduce the duration of tracheal intubation after uncomplicated cardiac surgery ("fast-track" surgery).


A group of patients being given ASV (group ASV) was compared with a control group (group control) in a randomized controlled study. After coronary artery bypass grafting during general anesthesia with midazolam and fentanyl, patients were randomly assigned to group ASV or group control. Both protocols were divided into three predefined phases, and weaning progressed according to arterial blood gas and clinical criteria. In phase 1, ASV mode was set at 100% of the theoretical value of volume/minute in group ASV, and synchronized intermittent mandatory ventilation mode was used in group control. When spontaneous breathing occurred, ASV setting was reduced by 50% of minute ventilation (phase 2) and again by 50% (phase 3), and the trachea was extubated. In group control, the ventilator was switched to 10 cm H2O inspiratory pressure support (phase 2), then to 5 cm H2O (phase 3) until extubation.


Forty-nine patients were enrolled. Sixteen patients completed the ASV protocol, and 20 the standard protocol; 7 patients were excluded in group ASV and 6 in group control according to explicit, predefined criteria. There were no differences between groups in perioperative characteristics or in the doses of sedation. The primary outcome of the study, that is, the duration of tracheal intubation, was shorter in group ASV than in group control (median [quartiles]: 3.2 [2.5-4.6] vs. 4.1 [3.1-8.6] h; P < 0.02). Fewer arterial blood analyses were performed in group ASV (median number [quartiles]: 3 [3-4] vs. 4 [3-6]), suggesting that fewer changes in the settings of the ventilator were required in this group.


A respiratory weaning protocol based on ASV is practicable; it may accelerate tracheal extubation and simplify ventilatory management in fast-track patients after cardiac surgery. The evaluation of potential advantages of the use of such technology on patient outcome and resource utilization deserves further studies.

RAPID tracheal extubation is a major component of “fast-track” recovery, progressively becoming a recommended strategy in uncomplicated cardiac surgery. This practice has been demonstrated to be safe in selected patients. 1It has resulted in reductions in (ICU) length of stay, hospital length of stay, resource utilization, and cost without adversely affecting mortality and morbidity. 2–6Different strategies have been proposed to reduce the duration of mechanical ventilation after cardiac surgery, including use of short-duration anesthetic drugs, 6standardization of patient care through “clinical pathways,”7and a reduction of the duration of cardiopulmonary bypass time and the depth of hypothermia. 8The extubation time after cardiac surgery is characterized by an optimal “window of opportunity”9that is determined by the adequacy of rewarming, control of hemodynamic problems, and postoperative bleeding. However, specific ventilatory strategies aimed at accelerating respiratory weaning after cardiac surgery have received little attention. 1 

Adaptive support ventilation (ASV) is a microprocessor-controlled mode of ventilation that maintains an operator preset, minimum minute ventilation, independent of the patient’s activity. Inspiratory pressure and ventilator rate are adjusted breath by breath to maintain an optimal respiratory pattern (tidal volume and respiratory rate). Previous studies have tested its efficiency, safety, and adaptability in lung models and in patients undergoing general anesthesia during position changes and transition between two- and one-lung ventilation. 10,11Adaptive support ventilation appropriately decreased ventilatory support in patients with chronic respiratory failure who tolerated a conventional weaning trial, 12suggesting that this mode may facilitate respiratory weaning.

We hypothesized that ASV could accelerate respiratory weaning after cardiac surgery. Therefore, we set out to determine whether a weaning protocol based on ASV resulted in a reduction in time to extubation in a randomized controlled trial.

Materials and Methods

After approval from the Ethics Committee of the Faculty of Medicine of the University of Lausanne (Lausanne, Switzerland), preoperative written informed consent was obtained from eligible patients. The study was conducted between June 1999 and February 2000 in the surgical ICU of our hospital. All patients scheduled for elective coronary artery bypass grafting under cardiopulmonary bypass were considered for enrollment. The preoperative exclusion criteria were age greater than 75 yr, poor myocardial function (preoperative ejection fraction < 30% by ventriculography), chronic obstructive pulmonary disease necessitating bronchodilator therapy, significant hepatic disease (alanine aminotransferase or aspartate aminotransferase values > 150 U/l), renal failure (creatinine value > 180 μm), or history of seizure and stroke. Clinical preoperative characteristics, including age, sex, Parsonnet cardiac surgery risk score according to Parsonnet et al. , 13and intraoperative data including anesthesia, cardiopulmonary bypass and aortic cross-clamp duration, left ventricular ejection fraction before and after bypass determined by transesophageal echocardiography, fentanyl and midazolam doses, and temperature on arrival in the ICU were recorded.

Patients were assigned at random to two parallel groups, one treated with an ASV-based protocol (group ASV), the other with a standard protocol of respiratory weaning (group control). Each code was indicated on a data form that was sealed in an envelope and opened upon the patient’s arrival in the ICU. After enrollment, the postoperative exclusion criteria included any conditions hindering the fast-track approach. These included severe postoperative hemorrhage (chest tube drainage > 500 ml/h, ≥ 350 ml/h during 2 h, or > 1,000 ml in total), repeat operation, postoperative myocardial ischemia, refractory hypoxemia (ratio of arterial oxygen tension to oxygen inspiratory fraction [Pao2/Fio2] < 150 at two arterial blood gas [ABG] analyses at an interval of 20 min each), and neurologic complication precluding the patient’s collaboration.

Clinical Management

Patient management was performed by the attending anesthesiologist and intensivist, and data collected by a research resident (Dr. Sulzer). The patients were anesthetized according to a protocol, including etomidate, fentanyl and vecuronium for induction and midazolam and low-dose fentanyl for maintenance. Cardiopulmonary bypass was performed under moderate hypothermia (28–32°C), using a membrane oxygenator and a nonpulsatile blood flow. At the end of anesthesia, all patients were transferred to the ICU with tracheal intubation, where they were also managed according to a standardized protocol, including fluid resuscitation with normal saline and starch solutions, blood transfusion to maintain hemoglobin concentration (≥ 7.0 g/dl), dopamine and norepinephrine in continuous infusion to achieve mean arterial pressure less than 70 mmHg; and sodium nitroprusside to treat hypertension above a mean arterial pressure of 100 mmHg. The patient’s requirement for analgesia was assessed by the nurse during the entire ICU stay. Morphine was given in a bolus of 1 or 2 mg intravenously, followed by a continuous infusion of 1 or 2 mg/h when the patient complained or expressed autonomic signs (e.g. , sweating, tachycardia, hypertension). The boluses were repeated as needed. During phase 1 of respiratory weaning, propofol was given for sedation in boluses of 20 or 30 mg to a Ramsey score of sedation greater than 3 (i.e. , responsive to commands). 14Shivering was treated with 25 mg intravenous pethidine.

Weaning Protocol

The ventilator used during the study was a Galileo with software version GBC 01.202 (Hamilton Medical AG, Rhäzüns, Switzerland). A thorough description of ASV technology has been reported elsewhere. 15Briefly, the theoretical value of minute ventilation was based on the nomogram of Radford 16and the patient’s ideal body weight. The initial settings of the ventilator consisted of three parameters: ideal body weight, the percentage of the theoretical value of minute ventilation desired (percentage minute ventilation), and the maximal inspiratory pressure tolerated. The ventilator determines the patient’s respiratory compliance and resistances during an initial test of five breaths and delivers a pressure-controlled ventilation, while optimizing inspiratory pressure and respiratory rate using the formula of Otis. 17The latter determines the respiratory rate associated with the least work of breathing as a function of the expiratory time constant. As soon as the patient performs an inspiratory effort, which is detected for every breath, the ventilator switches to inspiratory pressure support (IPS). The level of support is continuously adapted to the patient’s respiratory rate and tidal volume to achieve the desired minute ventilation using a favorable breathing pattern. Detrimental patterns such as rapid shallow breathing, excessive dead space ventilation, breath stacking (leading to automatic positive end-expiratory pressure), and excessively large breaths are prevented by adjustments of inspiratory pressure and respiratory rate. Thus, the system continuously adapts the ventilator’s settings to the patient’s needs. Both weaning protocols were divided in three phases designed to follow, in each mode, a similar process, using predefined criteria of poor tolerance to weaning (fig. 1and  appendix).

Fig. 1. Diagram of the three phases of the weaning protocol for the adaptive support ventilation group (ASV;right ) and the control group (left ). *Good tolerance denotes that the criteria of poor tolerance to weaning (see  appendix) were specifically ruled out before proceeding to the following phase. SIMV = synchronized intermittent mandatory ventilation; VT = tidal volume; RR = respiratory rate; Ppeak = peak airway pressure; PEEP = positive end-expiratory pressure; IPS = inspiratory pressure support.

Fig. 1. Diagram of the three phases of the weaning protocol for the adaptive support ventilation group (ASV;right ) and the control group (left ). *Good tolerance denotes that the criteria of poor tolerance to weaning (see  appendix) were specifically ruled out before proceeding to the following phase. SIMV = synchronized intermittent mandatory ventilation; VT = tidal volume; RR = respiratory rate; Ppeak = peak airway pressure; PEEP = positive end-expiratory pressure; IPS = inspiratory pressure support.

Upon admission, full ventilatory support (phase 1) was initiated in both groups. In group ASV, the initial ventilator settings were minute ventilation set at 100% of the theoretical value (100% minute ventilation), oxygen inspiratory fraction (Fio2) of 100%, positive end-expiratory pressure of 4 cm H2O (maintained constant until extubation), peak airway pressure of 25 cm H2O (peak airway pressure alarm set at 35 cm H2O), and flow trigger sensitivity of 2 l/min. An ABG analysis (Rapidlab Model 865 blood gas analyzer; Ciba-Corning Diagnostics AG, Dietlikon, Switzerland) was performed 10 min after connection to the ventilator to obtain an arterial carbon dioxide tension (Paco2) between 38 and 50 mmHg. If Paco2was 38 mmHg or less or more than 50 mmHg, minute ventilation was lowered or respectively increased by 20%. Each modification of the ventilator settings was controlled 10 min later by another ABG analysis. Adjustments were repeated until the Paco2was in the target. Fio2was adjusted to maintain an arterial oxygen saturation (Sao2) of 95% or more. Phase 1 lasted until patients breathed spontaneously at a frequency of 6 breaths/min or greater for 20 min; weaning could progress after ABG values were checked and clinical criteria of poor tolerance were ruled out ( appendix). The continuation of weaning was composed of two phases (phases 2 and 3) lasting at least 20 min each. In phase 2, minute ventilation was lowered by 50%. After 20 min, another assessment of the patient was performed. If clinical and ABG criteria indicated poor tolerance to weaning, mechanical ventilation of phase 1 was reinstated and the patient reassessed accordingly. If ABG and clinical criteria were satisfactory, the weaning progressed to phase 3, in which minute ventilation was lowered by another 50%. At the end of phase 3, if the patient achieved the extubation criteria ( appendix), a pulmonary physiotherapy was performed, followed by extubation. The patient was followed during his or her entire ICU stay for signs of respiratory failure requiring reintubation (criteria in  appendix). Intensive care unit length of stay was recorded.

In the standard group (group control), the initial settings for full ventilatory support (phase 1) were synchronized intermittent mandatory ventilation (SIMV) mode, tidal volume of 7 ml/kg with a decelerated flow waveform, 18and a respiratory rate of 12 breaths/min. Fio2, positive end-expiratory pressure, and flow trigger settings were identical to group ASV. An ABG analysis was performed after 10 min, and respiratory rate was lowered or respectively increased by 2 breaths/min, to satisfy Paco2criteria identical to group ASV. Each modification of the ventilator settings was controlled 10 min later by another ABG analysis, and the adjustments repeated in a manner similar to group ASV. When patients breathed spontaneously at a frequency of 6 breaths/min or greater for 20 min, weaning could progress to phase 2, according to the criteria defined for group ASV. The ventilatory mode was changed to IPS set at 10 cm H2O and apnea security at 20 s. After 20 min, another assessment of the patient was performed. If clinical or ABG criteria indicated poor tolerance to weaning, mechanical ventilation of phase 1 was reinstated and the patient reassessed accordingly. In case of apnea, the patient also returned to phase 1. If ABG and clinical criteria were complied with, the weaning progressed to phase 3, in which IPS was decreased to 5 cm H2O. At the end of phase 3, the patient was assessed and the trachea extubated according to the criteria described for group ASV.

Data and Measurements

In addition to the duration of respiratory weaning, several variables were recorded in the memory of a clinical monitor (Merlin; Hewlett-Packard, Geneva, Switzerland). Respiratory variables included tidal volume (tidal volume in milliliters), respiratory rate (counts per minute), and peak inspiratory pressure (peak airway pressure, centimeters of water). Heart rate, invasive arterial pressure, and arterial oxygen saturation (oxygen saturation measured by pulse oximetry) were monitored continuously and recorded every 5 min during the entire ICU stay. Continuous ST segment analysis was performed using derivations II and V5. The inflection point was determined manually, and measurement of ST depression or elevation was usually performed at 60–80 ms depending on heart rate. When that point fell within the T wave, it was shortened to a minimum of J + 40 ms. Postoperative myocardial ischemia was defined as reversible ST segment changes lasting at least 1 min and involving either a shift from baseline (adjusted for positional changes) of more than 1.0 mm (0.1 mV) of ST segment depression with a slope less than 0, or more than 2.0 mm of ST segment elevation at the J point. 19 

The duration of mechanical ventilation, as well as that of all three phases, was recorded; the durations constituted the primary outcome. The secondary outcomes were the amounts of sedative and analgesic drugs administered.

Statistical Analysis

The primary outcome variable was the duration of tracheal intubation. All other variables were considered as secondary. Durations of intubation and protocol phases and ICU length of stay were compared by log rank tests and were expressed as median [quartiles]. Nominal variables were compared between groups by chi-square tests. The continuous values are expressed as mean ± SD or median [quartiles]. For continuous variables, the mean values determined for each phase were compared by two-way analysis of variance for the effect of group and time. When the effect of time was significant, the values at each time were compared with the values at the preceding phases with Dunnett tests. When the interaction was significant, comparisons between groups and over time were performed with Scheffé tests. Because of marked bias of the distribution, the number of arterial blood gas analyses performed, as well as the amount of morphine and propofol administered at each phase, was compared by Wilcoxon tests with a modified Bonferronni correction. 20,P < 0.05 was considered statistically significant for all analyses. Statistical analysis was performed using JMP Statistical software (version 3.5.1; SAS Institute, Cary, NC). 21 


Of 49 patients enrolled in the study, 36 completed the weaning protocol and were considered in the statistical analysis. No patient was withdrawn for protocol failure or violation. Thirteen patients were withdrawn from the study (seven in group ASV vs.  six in group control). The reasons were myocardial ischemia (three and two, respectively), hypoxemia (two and four, respectively), stroke (one and none, respectively), and other neurologic problem (one and none, respectively). The occurrence was not different between groups (P = 0.56). The two groups were not different with respect to baseline and perioperative characteristics (table 1).

Table 1. Preoperative and Postoperative Clinical Characteristics

Mean ± SD unless otherwise specified.

ASV = adaptive support ventilation; CPB = cardiopulmonary bypass; ICU = intensive care unit.

Table 1. Preoperative and Postoperative Clinical Characteristics
Table 1. Preoperative and Postoperative Clinical Characteristics

The duration of mechanical ventilation was shorter in group ASV (193 [149–273] min) than in group control (243 [186–516] min) (P = 0.02). An a posteriori  analysis indicated that the power of this comparison was 57%. In this specific group of patients, a log rank test with an α value of 0.05 would have had a 90% probability of detecting a difference between groups of 120 min. The observed reduction in the intubation time was a result of a shortening of phase 1 (114 [78–230]vs.  171 [115–465] min) (P = 0.02), whereas phases 2 and 3 were not different (fig. 2and table 2).

Fig. 2. Kaplan-Meier curve of the cumulative rate of tracheal extubation over time for the adaptive support ventilation (ASV) and the control group. Extubation time was significantly shorter in the adaptive support ventilation group.

Fig. 2. Kaplan-Meier curve of the cumulative rate of tracheal extubation over time for the adaptive support ventilation (ASV) and the control group. Extubation time was significantly shorter in the adaptive support ventilation group.

Table 2. Respiratory, Hemodynamic, and Pharmacologic Variables of the Patients Completing the Study

ASV Group, n = 16; control Group, n = 20.

* A value different from the ASV group at the same step.

† A value different from the value at the previous step in the same group.

ASV = adaptive support ventilation; Ppeak = peak inspiratory pressure; RRV = respiratory rate; VT= tidal expiratory volume;p  Ha = arterial p  H; Paco2= arterial partial carbon dioxide pressure; Pao2/Fio2= ratio of arterial partial oxygen pressure to inspiratory oxygen concentration; ABG = arterial blood gas.

Table 2. Respiratory, Hemodynamic, and Pharmacologic Variables of the Patients Completing the Study
Table 2. Respiratory, Hemodynamic, and Pharmacologic Variables of the Patients Completing the Study

In a post hoc  analysis, considering fast-track success as an extubation within 6 h, we found that 27 patients succeeded, whereas 9 patients failed. More patients had successful extubation within 6 h in group ASV (15 of 16) than in group control (12 of 20) (P < 0.01). No reintubation was required in either group.

The respiratory variables are reported in table 2. Peak airway pressure was lower in group ASV during phase 1 (17.7 ± 0.5 vs.  20.4 ± 0.4 cm H2O) and in phase 2 (13.1 ± 0.5 vs.  16.0 ± 0.4 cm H2O). There was no difference during phase 3 (12.0 ± 0.5 vs.  12.0 ± 0.4 cm H2O). Tidal volume and respiratory rate were not different between groups. On analyzing the effect of time on all patients, peak airway pressure (19.1 ± 0.3 vs.  14.5 ± 0.3 cm H2O) and tidal volume (474 ± 9 vs.  448 ± 9 ml) decreased during phase 2, whereas respiratory rate increased (14.3 ± 0.4 vs.  17.3 ± 0.4 breaths/min). During phase 3, peak airway pressure further decreased (14.5 ± 0.3 vs.  12.0 ± 0.3 cm H2O). There was no difference in the mean tidal volume, respiratory rate, and positive end-expiratory pressure, as compared with phase 2. Paco2and the ratio of Paco2to Fio2did not differ between groups and over time (table 2). There were more ABG analyses performed in group control (3 [3–4]vs.  4 [3–6]), the difference being observed during phase 1. Intensive care unit length of stay was not different between groups.

The temperature increased from phase 1 to phase 2 similarly in both groups. The hemodynamic variables are reported in table 2. There were no differences between groups with regard to heart rate and arterial pressure. Heart rate increased significantly from phase 1 to phase 2 but not from phase 2 to phase 3. There was no difference between groups in the doses of propofol, morphine, and pethidine administered.


In the current randomized controlled study of respiratory weaning after uncomplicated cardiac surgery, a protocol based on ASV was compared with a standard one based on SIMV and IPS. The major finding was that the trachea was extubated earlier in group ASV, and this result was related to a reduction of the phase of full ventilatory support.

Weaning Strategy

To our knowledge, few studies have evaluated the efficacy of a specific ventilatory strategy to reduce the duration of intubation after fast-track cardiac surgery. 22,23In contrast, the reduction of mechanical ventilation by the implementation of clinical weaning protocols is well established in ICU patients requiring prolonged ventilation. 24–27Compared with physician-guided weaning based on judgment and experience, weaning-guided protocols focus the attention on the elements permitting a prompt identification of patient’s ability to sustain a reduction in ventilatory support, allowing a timely execution of respiratory weaning. 26,27This approach has received limited attention after cardiac surgery, although Wood et al. , 28in a retrospective study, pointed out the potential benefits of respiratory therapist–directed protocol over a physician-directed weaning.

Another strategy to facilitate respiratory weaning is to select the best ventilatory mode. 29–31In medical ICU patients requiring prolonged ventilatory support, Esteban et al.  31found that trials of spontaneous breathing with a T-piece were preferable to SIMV and IPS, whereas Brochard et al.  30showed that IPS was superior to the other modes. Thus, the choice of an optimal ventilatory mode during respiratory weaning is still controversial, but these studies suggest that specific modes may influence the duration of mechanical ventilation. After cardiac surgery, Rathgeber et al.  23compared three modes of ventilation and noted the advantage of biphasic intermittent positive airway pressure over SIMV and controlled mandatory ventilation. The study of Rathgeber et al.  23has methodologic limitations related to incomplete description of the study protocol and lack of randomization. However, it suggests that complex modes of pressure-controlled or assisted ventilation may facilitate ventilatory management of postoperative cardiac surgery patients by improving patient–ventilator interaction. Thus, both protocol implementation and specific ventilatory modes may accelerate tracheal extubation after cardiac surgery.

Adaptive Support Ventilation for Weaning

Adaptive support ventilation provides a ventilation in a pressure mode (pressure-controlled ventilation), as well as an automatic switch from pressure-controlled ventilation to IPS. In group ASV, we observed a significant reduction in intubation time that was related to a faster recovery of spontaneous ventilation, as indicated by a shorter phase of controlled ventilation (phase 1). This observation suggests that patient–machine interaction could have been improved in comparison to the SIMV ventilation.

Mechanical ventilation with ASV was possible in all the patients, including those with moderate respiratory failure (Pao2/Fio2ratio between 150 and 300 mmHg), while respecting the limits of inspiratory pressure. The lower number of ABG analyses in group ASV indicates that fewer changes of the respiratory settings were necessary, suggesting that ASV may simplify the management of respiratory weaning.

The effect of different ventilatory modes on clinical outcomes is often difficult to assess. For each mode, a protocol must be implemented that guarantees not only safety but also efficacy during mechanical ventilation and weaning. 26,32The criteria for making clinical decisions such as increasing or reducing ventilatory support or extubating the trachea must be detailed and explicit. 31,33This guarantees the safety and efficacy of the weaning process and minimizes observer’s bias and variability. Thus, the current study was divided into three phases defined by explicit criteria (fig. 1). The end of each phase was determined by criteria that were identical in both protocols, guaranteeing an objective comparison between the two ventilatory modes.

Limitations of Study

Despite the limited number of patients included in our study, they were randomly assigned to one of two groups. The groups were well matched for nine perioperative variables known to influence the duration of postoperative ventilation (table 1). The number of dropouts (27%), attributable to conditions known to disturb the fast-track process, may appear substantial. It is unlikely that it invalidates the results because both number and reasons for dropouts were balanced between groups. Published randomized controlled trials on fast-track process after cardiac surgery, using similar inclusion criteria and end points, have reported an incidence of severe adverse events or dropping out ranging from 20 to 40%. 3,4,34In the present study, most adverse events were prospectively defined as exclusion criteria; this could explain the observed rate of dropouts. Therefore, we believe that the results of this preliminary study are valid under the specific conditions of our practice. The lack of difference in ICU length of stay suggests that no major difference in resource utilization occurred, despite a reduction in the number of manipulations of settings. Thus, further investigations including a cost efficiency analysis are required before the precise role of ASV can be firmly established for respiratory weaning after cardiac surgery.

The present study suggests that a weaning protocol based on ASV is practicable and that it may accelerate tracheal extubation in patients who completed a fast-track protocol after cardiac surgery under the condition of cardiopulmonary bypass. This acceleration is related to a faster recuperation of sustained spontaneous ventilation, which might be related to an improved patient–machine interaction. Adaptive support ventilation was also feasible in patients presenting a moderate respiratory failure, a common finding after cardiopulmonary bypass. The evaluation of potential advantages of the use of such technology on patient outcome and resource utilization deserves further studies.

The authors thank Guy Van Melle, Ph.D. (Institute of Social and Preventive Medicine, University of Lausanne, Laussane, Switzerland), for statistical advice and the nursing team of the surgical intensive care unit for their active collaboration.


Criteria of Poor Tolerance to Weaning

Mechanical ventilation was returned to the previous step if any of the following occurred:

  • respiratory rate ≥ 35 breaths/min

  • arterial oxygen saturation < 90%

  • heart rate > 140 beats/min or a sustained increase or decrease in the heart rate of more than 20%

  • systolic blood pressure > 200 mmHg or < 90 mmHg

  • agitation

  • diaphoresis

  • arterial carbon dioxide tension (Paco2) > 50 mmHg

Tracheal Extubation Criteria

Extubation was performed when all of the following were present:

  • patient responsive and cooperative

  • oxygen inspiratory fraction (Fio2) ≤ 50%; positive end-expiratory pressure = 5 cm H2O, ratio of arterial oxygen tension (Pao2) to Fio2> 150

  • hemodynamically stable, well perfused, urine output > 0.5 ml · kg−1· h−1

  • chest tube drainage < 200 ml in the last hour

  • absence of uncontrolled arrhythmia

  • rectal temperature > 36.0°C

Reintubation Criteria

Reintubation was performed if any of the following were present:

Respiratory causes:

  • acute respiratory failure: Pao2> 60 mmHg with Fio2≥ 60% by ventilation mask; Paco2> 50 mmHg and pH < 7.30

  • respiratory rate > 40 breaths/min with physical signs of distress

Nonrespiratory causes:

  • acute deterioration of level of consciousness or new onset of global neurologic deficit

  • inability to protect the airway from aspiration of oropharyngeal secretions and gastric contents because of neurologic dysfunction or altered level of consciousness

  • severe hemodynamic instability or cardiogenic shock


Ali MJ, Cheng DCH: Advances in cardiac anesthesia techniques and intensive care. New Horiz 1999; 7: 451–461
Cheng DCH, Karski J, Peniston C, Raveendran G, Asokumar B, Carroll J, David T, Sandler A: Early tracheal extubation after coronary artery bypass graft surgery reduces costs and improves resource use. Anesthesiology 1996; 85: 1300–10
Cheng DCH, Karski J, Peniston C, Asokumar B, Raveendran G, Carroll J, Nierenberg H, Roger S, Mickle D, Tong J, Zelovitsky J, David T, Sandler A: Morbidity outcome in early versus conventional tracheal extubation after coronary artery bypass grafting: A prospective randomized controlled trial. J Thorac Cardiovasc Surg 1996; 112: 755–64
Silbert BS, Santamaria JD, O’Brien JL, Blyth CM, J KW, Molnar RR: Early extubation following coronary artery bypass surgery. Chest 1998; 113:1481–8
London MJ, Shroyer AL, Coll JR, MaWhinney S, Fullerton DA, Hammermeister KE, Grover FL: Early extubation following cardiac surgery in a veterans population. Anesthesiology 1998; 88: 1447–58
Cheng DCH: Impact of early tracheal extubation on hospital discharge. J Cardiothorac Vasc Anesth 1998; 12: 35–40
Cheng DCH: Fast track cardiac surgery pathways. Anesthesiology 1998; 88: 1429–33
Birdi I, Regragui IA, Izzat MB, Alonso C, Black AM, Bryan AJ, Angelini GD: Effects of cardiopulmonary bypass temperature on pulmonary gas exchange after coronary artery operations. Ann Thorac Surg 1996; 61: 118–23
Higgins TL: Safety issues regarding early extubation after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1995; 9: 24–9
Weiler N, Heinrichs W, Kessler W: The ALV-mode: A safe closed loop algorithm for ventilation during total intravenous anesthesia. Int J Clin Monit Comput 1994; 11: 85–8
Weiler N, Eberle B, Heinrichs W: Adaptive lung ventilation (ALV) during anesthesia for pulmonary surgery: Automatic response to transitions to and from one-lung ventilation. J Clin Monit Comput 1998; 14: 245–52
Linton DM, Potgieter PD, Davis S, Fourie ATJ, Brunner JX, Laubscher TP: Automatic weaning from mechanical ventilation using an adaptive lung ventilation controller. Chest 1994; 106: 1843–50
Parsonnet V, Dean D, Bernstein AD: A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989; 79: I3–12
Ramsay MA, Savege TM, Simpson BR, Goodwin R: Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656–9
Laubscher TP, Heinrichs W, Weiler N, Hartman G, Brunner JX: An adaptive lung ventilation controller. IEEE Trans Biomed Eng 1994; 41: 51–9
Radford EP: Ventilation standards for use in artificial respiration. N Engl J Med 1954; 251: 877–83
Otis AB, Fenn WO, Rahn H: Mechanics of breathing in man. J Appl Physiol 1950; 2: 592–607
Davis K, Branson RD, Campbell RS, Porembka DT: Comparison of volume control and pressure control ventilation: Is flow waveform the difference? J Trauma 1996; 41: 808–14
Mangano DT, Siliciano D, Hollenberg M, Leung JM, Browner WS, Goehner P, Merrick S, Verrier E: Postoperative myocardial ischemia. Anesthesiology 1992; 76: 342–53
Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800–3
JMP®Statistics and Graphics Guide, version 3.1. Cary, SAS Institute, 1995
Hastings PR, Bushnell LS, Skillman JJ, Weintraub RM, Hedley-Whyte J: Cardiorespiratory dynamics during weaning with IMV versus  spontaneous ventilation in good-risk cardiac-surgery patients. Anesthesiology 1980; 53: 429–31
Rathgeber J, Schorn B, Falk V, Kazmaier S, Spiegel T, Burchardi H: The influence of controlled mandatory ventilation (CMV), intermittent mandatory ventilation (IMV) and biphasic intermittent positive airway pressure (BIPAP) on duration of intubation and consumption of analgesics and sedatives: A prospective analysis in 596 patients following adult cardiac surgery. Eur J Anaesthesiol 1997; 14: 576–82
Saura P, Blanch L, Mestre J, Valles J, Artigas A, Fernandez R: Clinical consequences of the implementation of a weaning protocol. Intensive Care Med 1996; 22: 1052–6
Horst HM, Mouro D, Hall-Jenssens RA, Pamukov N: Decrease in ventilation time with a standardized weaning process. Arch Surg 1998; 133: 483–9
Kollef MH, Shapiro SD, Silvert P, St. John RE, Prentice D, Sauer S, Ahrens TS, Shannon W, Baker-Clinkscale D: A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 1997; 25: 567–74
Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelly PT, Johnson MM, Browder RW, Bowton DL, Haponik EF: Effect of the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335: 1864–9
Wood G, MacLeod B, Moffatt S: Weaning from mechanical ventilation: Physician-directed vs a respiratory-therapist-directed protocol. Respir Care 1995; 40: 219–24
Tomlinson JR, Miller KS, Lorch DG, Smith L, Reines HD, Sahn SA: A prospective comparison of IMV and T-piece weaning from mechanical ventilation. Chest 1989; 96: 348–52
Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gasparetto A, Lemaire F: Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 1994; 150: 896–903
Esteban A, Frutos F, Tobin MJ, Alia I, Solsona JF, Valverdu I, Fernandez R, de la Cal MA, Benito S, Tomas R, Carriedo D, Macias S, Blanco J: A comparison of four methods of weaning from mechanical ventilation: Spanish Lung Failure Collaborative Group. N Engl J Med 1995; 332: 345–50
Morris AH: Developing and implementing computerized protocols for standardization of clinical decisions. Ann Intern Med 2000; 132: 373–83
Knebel AR, Janson-Bjerklie SL, Malley JD, Wilson AG, Marini JJ: Comparison of breathing comfort during weaning with two ventilatory modes. Am J Respir Crit Care 1994; 149: 14–8
Chaney MA: Intrathecal and epidural anesthesia and analgesia for cardiac surgery. Anesth Analg 1997; 84: 241–8